>FASTA_35

GLP-1 gene therapy; Menstrual blood; Bugs as bioreactors; Rejuvenation clinical trials; Plant-based engine lubricants; Ready-to-drink creatine; Biotech fragrances; Human design.

>FASTA: short reads of the biotech ecosystem beyond trad-pharma | Papers and patents, acquisitions and bankruptcies + biotech philosophy | Follow on LinkedIn, X, and Instagram.

1. Fractyl Health ($GUT) is developing a GLP-1 gene therapy.

2. Muse bio collects menstrual blood donations for stem cell research.

3. Chilean startup ByBug uses fly larvae as protein biofactories.

4. David Sinclair’s Life Bioscience will begin human trials this year.

5. BioProtocol just launched a new men’s health supplement.

6. Enzymatic conversion of blood groups for kidney donation.

7. DGP’s plant-based engine lubricants sell in Home Depots across the US.

8. Cymbiotika cracked the code to ready-to-drink creatine.

9. Abel re-launched as a biotech-based fragrance house.

10. Poets: the rise of wellness & looks-maxxing coaches.

Become a Biopunk member to read more about all of these!